Social Media Ideas for Bayer

Latest updates for Bayer

Fresh curated links around Bayer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

cafepharma.com /2 weeks ago

Opportunity with Bayer (Diabetes Care)

Opportunity with Bayer (Diabetes Care) Anonymous (not verified) Sun, 08/23/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/opportunity-...

Read source

thehindubusinessline.com /2 days ago

Bayer to bring 10 products to world market in 10 years

In soy, ‘Vyconic 1’ is expected to be introduced next year in the US and Canada, and ‘Intacta 5+’ is expected to be introduced in the 2027-28 growing season in Brazil

Read source

cafepharma.com /2 weeks ago

Bayer Diabetes - What's going on?

Bayer Diabetes - What's going on? Anonymous (not verified) Sun, 08/23/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/bayer-diabetes-wh...

Read source

seekingalpha.com /1 month ago

Bayer: Debt Remains A Problem, Value Remains Compelling

Read source

law360.com /1 month ago

Bayer Defends Fees For Seed Tech With Expired Patents

Bayer asked a Missouri federal judge to dismiss a sweeping antitrust proposed class action, arguing that the independent seed company suing it, in a complaint that also includes br...

Read source

law360.com /1 month ago

J&J Says Cancer Drug Study Sinks Bayer's False Ad Claims

Johnson & Johnson told a New York federal court that a peer-reviewed scientific journal's publication of a study on the active ingredient in its prostate cancer drug must end B...

Read source

pharmexec.com /3 weeks ago

<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...

Read source

fiercebiotech.com /3 days ago

Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win

Roivant’s $14 million bet on a pulmonary hypertension drug from Bayer appears to have paid off as the inhaled med aced a phase 2 lung disease study.

Read source

pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta]]>

Read source

pharmexec.com /1 month ago

<![CDATA[Eli Lilly to Acquire AtaiBeckley for $2.8 Billion ]]>

Read source

cafepharma.com /1 month ago

Hoechst-Roussel

Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...

Read source

handelsblatt.com /1 month ago

Dermapharm: Fall Reppegather wird zum Problem für Pharma-Milliardär Beier

Die Bafin soll Geschäfte des Pharmakonzerns Dermapharm mit den Reppegather-Brüdern prüfen. Es geht um eine Millionenforderung und mögliche Verstöße gegen Bilanzvorschriften.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.